We are live on ! Find out more
IBBQ icon

Invesco NASDAQ Biotechnology ETF
IBBQ

12 hedge funds and large institutions have $8.92M invested in Invesco NASDAQ Biotechnology ETF in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

33% more funds holding

Funds holding: 9 → 12 (+3)

4% more capital invested

Capital invested by funds: $8.59M → $8.92M (+$331K)

9.42% less ownership

Funds ownership: 54.33% → 44.91% (-9.4%)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RJFSA
Raymond James Financial Services Advisors
Florida
+$502K
2
LSAG
Lake Street Advisors Group
New Hampshire
+$254K
3
PCIG
Partners Capital Investment Group
Massachusetts
+$254K
4
CIAS
Capital Investment Advisory Services
North Carolina
+$12.9K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$5.32K

Top Sellers

Rank Fund Capital Flow
1
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$587K
2
TRCT
Tower Research Capital (TRC)
New York
-$107K
3
BBP
Banco BTG Pactual
Brazil
-$14.1K
4
CAL
Capital Analysts LLC
Pennsylvania
-$13.9K
5
UBS Group
UBS Group
Switzerland
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Mirae Asset Global Investments
1
Mirae Asset Global Investments
South Korea
$5.65M -$587K -29,600 -9%
BBP
2
Banco BTG Pactual
Brazil
$725K -$14.1K -708 -2%
TRCT
3
Tower Research Capital (TRC)
New York
$712K -$107K -5,415 -13%
RJFSA
4
Raymond James Financial Services Advisors
Florida
$478K +$502K +25,273 New
CGL
5
Clarius Group LLC
Washington
$356K +$754 +38 +0.2%
Bank of America
6
Bank of America
North Carolina
$268K -$1.41K -71 -0.5%
LSAG
7
Lake Street Advisors Group
New Hampshire
$242K +$254K +12,806 New
PCIG
8
Partners Capital Investment Group
Massachusetts
$242K +$254K +12,806 New
CIAS
9
Capital Investment Advisory Services
North Carolina
$215K +$12.9K +650 +6%
Morgan Stanley
10
Morgan Stanley
New York
$20K – – –
CAL
11
Capital Analysts LLC
Pennsylvania
$9K -$13.9K -700 -58%
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$5K +$5.32K +268 New
UBS Group
13
UBS Group
Switzerland
– -$3K -170 Closed

IBBQ Hedge Fund Activity: Q3 2022 in Review

12 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q3 2022, worth a combined $8.92M — up 3.9% from $8.59M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IBBQ positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Raymond James Financial Services Advisors, opening a new position worth an estimated $502K. The largest seller was Mirae Asset Global Investments, cutting an estimated $587K.

  • 12 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q3 2022, up from 9 in Q2 2022.
  • Funds reported $8.92M of Invesco NASDAQ Biotechnology ETF stock for Q3 2022, up 3.9% quarter-over-quarter.
  • 4 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q3 2022 and 1 closed out, a net change of +3 holders.
  • The largest Invesco NASDAQ Biotechnology ETF buyer in Q3 2022 was Raymond James Financial Services Advisors, an estimated $502K added.
  • The largest Invesco NASDAQ Biotechnology ETF seller in Q3 2022 was Mirae Asset Global Investments, an estimated $587K sold.

Based on aggregated 13F filings for Q3 2022.